These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12489366)

  • 1. Understanding and preparing for clinical drug trial audits.
    Siden R; Tankanow RM; Tamer HR
    Am J Health Syst Pharm; 2002 Dec; 59(23):2301, 2306, 2308. PubMed ID: 12489366
    [No Abstract]   [Full Text] [Related]  

  • 2. Audits of radiopharmaceutical formulations.
    Castronovo FP
    Am J Hosp Pharm; 1992 Mar; 49(3):584-90. PubMed ID: 1598931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing oncology research protocols.
    Lunik MC
    Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dispensing investigational drugs: regulatory issues and the role of the investigational drug service.
    Shehab N; Tamer H
    Am J Health Syst Pharm; 2004 Sep; 61(18):1882-4. PubMed ID: 15487876
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA investigational new drug requirements.
    McElvany KD
    Front Neurol Neurosci; 2009; 25():62-65. PubMed ID: 19478498
    [No Abstract]   [Full Text] [Related]  

  • 6. Operation of a radiopharmacy for a clinical trial.
    Norenberg JP; Petry NA; Schwarz S
    Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation of new animal drugs by veterinary practitioners.
    Prater DA; Bertone JJ; Letonja T; Vaughn SD
    J Am Vet Med Assoc; 1996 Jan; 208(2):190-4. PubMed ID: 8567369
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanics of the Food and Drug Administration's Form 1571: investigational new drug application.
    Novack G
    Retina; 2005 Dec; 25(8 Suppl):S96-S97. PubMed ID: 16374362
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 10. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K
    J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers to clinical trials vary according to the type of trial and the institution.
    Govindarajan R; Young JW; Harless CL; Hutchins LF
    J Clin Oncol; 2007 Apr; 25(12):1633-4; author reply 1634. PubMed ID: 17443010
    [No Abstract]   [Full Text] [Related]  

  • 13. Abbreviated clinical study reports with investigational medicinal products for human use: current guidelines and recommendations.
    Alfaro V; Cullell-Young M; Tanovic A
    Croat Med J; 2007 Dec; 48(6):871-7. PubMed ID: 18074423
    [No Abstract]   [Full Text] [Related]  

  • 14. Pre-approval inspections/investigations. Food and Drug Administration.
    J Parenter Sci Technol; 1991; 45(1):56-66. PubMed ID: 2007970
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology and first-time-in-man studies: the FDA levels the playing field.
    Luderer J; Piergies AA; Jorkasky D; Sedman A; Reele S; Froehlich J; Cavanaugh J; Steinman GL
    J Clin Pharmacol; 1996 Mar; 36(3):187-8. PubMed ID: 8690810
    [No Abstract]   [Full Text] [Related]  

  • 16. Tighter safety controls needed over clinical trials, says FDA.
    Am J Health Syst Pharm; 1995 Feb; 52(4):357. PubMed ID: 7757854
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA treads delicate line between safety and speed.
    Oncology (Williston Park); 1999 Jan; 13(1):16. PubMed ID: 10027195
    [No Abstract]   [Full Text] [Related]  

  • 18. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):701. PubMed ID: 24073621
    [No Abstract]   [Full Text] [Related]  

  • 19. The exploratory IND.
    Mills G
    J Nucl Med; 2008 Jun; 49(6):45N-47N. PubMed ID: 18511824
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical quality assurance in the pharmaceutical industry.
    Donahue JJ
    Cancer Treat Rep; 1985 Oct; 69(10):1195-7. PubMed ID: 4042098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.